BioXcel Therapeutics, Inc. (BTAI) › Shares OutstandingBioXcel Therapeutics, Inc. (BTAI) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2017: 9.91M2018: 15.66M2019: 18.09M2020: 24.42M2021: 27.98M2022: 28.15M2023: 1.87M2024: 3.10M2025: 22.33M22.33M2017Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202522.33M+619.8%20243.10M+65.8%20231.87M-93.4%202228.15M+0.6%202127.98M+14.6%202024.42M+35.0%201918.09M+15.5%201815.66M+58.1%20179.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share